Post-thaw dimethyl sulfoxide reduction in autologous peripheral blood progenitor cell suspensions
Background and objectives: Dimethyl sulfoxide has become the most common cryoprotectant used for cryopreservation of hematopoietic progenitor cells because of its efficiency, regardless of its potentially toxic side effects. Its application is considered safe, provided that the daily dose administer...
Saved in:
| Main Authors: | Miroslava Jandová, Pavel Měřička, Jiří Gregor, Miriam Lánská, Aleš Bezrouk, Dana Čížková, Jakub Radocha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-10-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925002330 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitory effect of dimethyl sulfoxide on the development of gastrointestinal nematode larvae in the larval development test
by: Mickiewicz Marcin, et al.
Published: (2025-03-01) -
Dimethyl sulfoxide in cryopreserved mesenchymal stromal cell therapy products: is there a safety risk to patients?
by: Elke Niebergall-Roth, et al.
Published: (2025-08-01) -
The Toxicity of Dimethyl Sulfoxide Combined with the Alkylating Agent MNU on Mice: Focusing on Mortality and Activity Impairment
by: Yan W, et al.
Published: (2025-07-01) -
Ice recrystallization inhibitors enable efficient cryopreservation of induced pluripotent stem cells: A functional and transcriptomic analysis
by: Kathleen Mommaerts, et al.
Published: (2024-12-01) -
DMSO-free cryopreservation of hiPSC-derived cardiomyocytes: low temperature characterization and protocol development
by: Akshat S. Mallya, et al.
Published: (2025-06-01)